Abstract

The increased mass of airway smooth muscle (ASM) in the airways of asthmatic patients may contribute to the pathology of this disease by increasing the capacity for airway narrowing. Evidence for the airway epithelium as a participant in ASM remodeling is accruing. To investigate mechanisms by which airway epithelial cells induce ASM cell (ASMC) proliferation, we have employed a co-culture model to explore markers of ASMC proliferative phenotype. Co-culture with epithelial cells led to incorporation of bromodeoxyuridine into ASMCs, indicating augmented proliferation and an associated increase in mRNA of the pro-proliferative co-transcription factor Elk1. Although the mitogen heparin-binding epidermal growth factor (HB-EGF) was augmented in the co-culture supernatant, the ASMC epidermal growth factor receptor (EGFR), an effector of HB-EGF induced proliferation, did not mediate epithelial-induced proliferation. The co-culture increased the expression of ASMC mRNA for the pro-inflammatory cytokines IL-6 and IL-8 as well as the pro-proliferative microRNA miR-210. The transcriptional repressor Max-binding protein (Mnt), a putative target of miR-210, was transcriptionally repressed in co-cultured ASMCs. Together, these data indicate that the airway epithelium-induced proliferative phenotype of ASMCs is not driven by EGFR signaling, but rather may be dependent on miR210 targeting of tumor suppressor Mnt.

Highlights

  • Asthma is a chronic disease of the airways that is estimated to affect 300 million individuals globally

  • We have demonstrated that ASM cell (ASMC) undergo increased rates of proliferation after co-culture with epithelial cells

  • Despite a strong rationale for exploring the epidermal growth factor receptor (EGFR) in mediating Airway smooth muscle (ASM) proliferation, our results do not support the role of heparin-binding epidermal growth factor (HB-EGF) or other EGFR ligands as mediators of the ASM proliferation

Read more

Summary

Introduction

Asthma is a chronic disease of the airways that is estimated to affect 300 million individuals globally The pathophysiology of this disease involves airway wall remodeling including increased mass of smooth muscle (Dunnill et al, 1969; Ebina et al, 1993). Increased ASM mass may be the most important factor contributing to increased airway resistance and excessive responsiveness to contractile agonists (Lambert et al, 1993). Several cellular sources of increased ASM have been postulated, including epithelial–mesenchymal transition (Berair et al, 2013), myofibroblast differentiation (Hautmann et al, 1997), and migration (Salter et al, 2017). An additional plausible source of increased ASM in the asthmatic airway is an increased proliferation of pre-existing ASM cells (AMSCs) (Ebina et al, 1993; Johnson et al, 2001; Woodruff et al, 2004)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call